IOCAS-IR  > 海洋生物技术研发中心
Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
Yu, Xinfeng1; Zhang, Quanbin2; Cui, Wentong1; Zeng, Zheng1; Yang, Wenzhe1; Zhang, Chao1; Zhao, Hongwei1; Gao, Weidong3; Wang, Xiaomin4; Luo, Dali1; Luo, DL (reprint author), Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Youanmenwai St,10 Xitoutiao, Beijing 100069, Peoples R China.
2014
发表期刊JOURNAL OF DIABETES RESEARCH
页码420929
文章类型Article
摘要Diabetic cardiomyopathy (DCM) is characterized by cardiac dysfunction and cardiomyocyte apoptosis. Oxidative stress is suggested to be the major contributor to the development of DCM. This study was intended to evaluate the protective effect of low molecular weight fucoidan (LMWF) against cardiac dysfunction in diabetic rats. Type 2 diabetic goto-kakizaki rats were untreated or treated with LMWF (50 and 100 mg/kg/day) for three months. The establishment of DCM model and the effects of LMWF on cardiac function were evaluated by echocardiography and isolated heart perfusion. Ventricle staining with H-E or Sirius Red was performed to investigate the structural changes in myocardium. Functional evaluation demonstrated that LMWF has a beneficial effect on DCM by enhancing myocardial contractility and mitigating cardiac fibrosis. Additionally, LMWF exerted significant inhibitory effects on the reactive oxygen species production and myocyte apoptosis in diabetic hearts. The depressed activity of superoxide dismutase in diabetic heart was also improved by intervention with LMWF. Moreover, LMWF robustly inhibited the enhanced expression of protein kinase C beta, an important contributor to oxidative stress, in diabetic heart and high glucose-treated cardiomyocytes. In conclusion, LMWF possesses a protective effect against DCM through ameliorations of PKC beta-mediated oxidative stress and subsequent cardiomyocyte apoptosis in diabetes.
学科领域Endocrinology & Metabolism ; Research & Experimental Medicine
DOI10.1155/2014/420929
收录类别SCI
语种英语
WOS记录号WOS:000346293300001
引用统计
被引频次:28[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.qdio.ac.cn/handle/337002/24231
专题海洋生物技术研发中心
通讯作者Luo, DL (reprint author), Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Youanmenwai St,10 Xitoutiao, Beijing 100069, Peoples R China.
作者单位1.Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing 100069, Peoples R China
2.Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China
3.Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA
4.Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China
推荐引用方式
GB/T 7714
Yu, Xinfeng,Zhang, Quanbin,Cui, Wentong,et al. Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis[J]. JOURNAL OF DIABETES RESEARCH,2014:420929.
APA Yu, Xinfeng.,Zhang, Quanbin.,Cui, Wentong.,Zeng, Zheng.,Yang, Wenzhe.,...&Luo, DL .(2014).Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis.JOURNAL OF DIABETES RESEARCH,420929.
MLA Yu, Xinfeng,et al."Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis".JOURNAL OF DIABETES RESEARCH (2014):420929.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Low Molecular Weight(5068KB) 限制开放ODC PDDL浏览
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yu, Xinfeng]的文章
[Zhang, Quanbin]的文章
[Cui, Wentong]的文章
百度学术
百度学术中相似的文章
[Yu, Xinfeng]的文章
[Zhang, Quanbin]的文章
[Cui, Wentong]的文章
必应学术
必应学术中相似的文章
[Yu, Xinfeng]的文章
[Zhang, Quanbin]的文章
[Cui, Wentong]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。